Back to the main directory
EarningsReview / Equity
- TGS Nopec (Buy, TP: NOK270.00) - Softer market outlook by DnB Markets
- Outotec (Buy, TP: EUR7.00) - Direction of travel looks good by DnB Markets
- Star Bulk (Buy, TP: USD11.50) - Robust dry bulk market boosts estimates by DnB Markets
- SalMar (Sell, TP: NOK350.00) - Minor model adjustments by DnB Markets
- Transocean (Buy, TP: USD10.00) - Disciplined message by DnB Markets
- Alligator Bioscience (Buy, TP: SEK29.00) - Termination of ADC-1013 deal by DnB Markets
- Scorpio Tankers (Buy, TP: USD35.00) - Waiting for H2 tailwinds by DnB Markets
- Ambea (Buy, TP: SEK84.00) - Reinstating recommendation by DnB Markets
- Teekay Tankers (Buy, TP: USD2.20) - Markets likely to tighten by DnB Markets
- SalMar (Hold, TP: NOK440.00) - Uneventful is good by DnB Markets
- Grieg Seafood (Buy, TP: NOK135.00) - Look to Norway by DnB Markets
- Ice Group (Buy, TP: NOK34.00) - Underlying growth KPIs improving by DnB Markets
- Ice Group (Buy, TP: NOK34.00) - Underlying growth KPIs improving by DnB Markets
- Magseis Fairfield (Buy, TP: NOK18.00) - Building a market leader by DnB Markets
- Konecranes Minor model adjustments by DnB Markets
- Genco Shipping & Trading Minor model adjustments by DnB Markets
- NeuroVive Pharmaceutical Fast track for NeuroSTAT by DnB Markets
- NeuroVive Pharmaceutical NeuroSTAT milestone by DnB Markets
- Mr Price (MRP SJ) by HSBC
- Rio Tinto Plc (RIO LN) by HSBC
- Mapletree Commercial Trust (MCT SP) by HSBC
- SK Hynix Inc. (000660 KS) by HSBC
- East Money Information (300059 CH) by HSBC
- Vinhomes JSC (VHM VM) by HSBC
- UPL (UPLL IN) by HSBC
- Hexagon AB (Hold, TP: SEK480.00) - Chinese growth engine stalled by DnB Markets
- Safe Bulkers (Buy, TP: USD2.40) - NAV raised on resurrected rates by DnB Markets
- Veoneer (Buy, TP: SEK270.00) - A step closer to 2020e turnaround by DnB Markets
- Eagle Bulk Shipping (Buy, TP: USD5.70) - Back at 0.8x P/NAV by DnB Markets
- Lerøy Seafood (Hold, TP: NOK60.00) - Minor model update by DnB Markets
- Securitas (Buy, TP: SEK175.00) - Q2 without the right momentum by DnB Markets
- Humana (Buy, TP: SEK68.00) - Short-term pain, long-term gain by DnB Markets
- Hexagon Composites (Buy, TP: NOK41.00) - Easing concerns; upgraded to BUY by DnB Markets
- Valaris (Buy, TP: USD15.00) - Consensus needs a reality check by DnB Markets
- Frontline (Buy, TP: NOK89.00) - Accretive 18% fleet growth by DnB Markets
- Wallenius Wilhelmsen ASA (Hold, TP: NOK23.00) - 32% below consensus 2020e by DnB Markets
- Targovax (Buy, TP: NOK7.00) - All focus on ONCOS by DnB Markets
- Wilh. Wilhelmsen Holding (Buy, TP: NOK198.00) - Strong underlying cash generation by DnB Markets
- Asarina Pharma (Buy, TP: SEK44.00) - Encouraging pre-clinical data by DnB Markets
- FLSmidth Minor model adjustments by DnB Markets
- Isofol Medical Encouraging progress by DnB Markets
- Atvexa Continued strong growth by DnB Markets
- Swedish Stirling by DnB Markets
- Keppel REIT (KREIT SP) by HSBC
- LG Display (034220 KS) by HSBC
- GlaxoSmithKline (GSK LN) by HSBC
- SK Innovation (096770 KS) by HSBC
- Hui Xian REIT (87001 HK) by HSBC
- Chroma ATE (2360 TT) by HSBC
- Elementis Plc (ELM LN) by HSBC